Zhengye Biotechnology Holding (ZYBT) Receivables - Other (2023 - 2025)
Zhengye Biotechnology Holding has reported Receivables - Other over the past 3 years, most recently at $104052.5 for Q4 2025.
- Quarterly Receivables - Other rose 1.28% to $104052.5 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $104052.5 through Dec 2025, up 1.28% year-over-year, with the annual reading at $102694.8 for FY2025, 71.47% down from the prior year.
- Receivables - Other was $104052.5 for Q4 2025 at Zhengye Biotechnology Holding, up from $103000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $180831.4 in Q4 2023 and troughed at $102741.2 in Q4 2024.
- The 3-year median for Receivables - Other is $103526.3 (2025), against an average of $122656.3.
- Year-over-year, Receivables - Other plummeted 43.18% in 2024 and then increased 1.28% in 2025.
- A 3-year view of Receivables - Other shows it stood at $180831.4 in 2023, then plummeted by 43.18% to $102741.2 in 2024, then rose by 1.28% to $104052.5 in 2025.
- Per Business Quant, the three most recent readings for ZYBT's Receivables - Other are $104052.5 (Q4 2025), $103000.0 (Q2 2025), and $102741.2 (Q4 2024).